1021489-55-3 Usage
Uses
1. Used in Pharmaceutical Applications:
SPT1141 M6 is used as a pharmaceutical agent for its potential therapeutic effects. The compound's ability to interact with biopolymers and macromolecules makes it a promising candidate for the development of new drugs and treatments.
2. Used in Drug Delivery Systems:
SPT1141 M6 is used as a component in drug delivery systems to improve the efficacy and bioavailability of various medications. Its compatibility with different carriers, such as organic and metallic nanoparticles, allows for the development of novel drug delivery methods that can enhance the therapeutic outcomes of existing drugs.
3. Used in Anticancer Applications:
In the field of oncology, SPT1141 M6 is used as an anticancer agent, particularly for treating various types of cancer. It can modulate several oncological signaling pathways, exerting inhibitory effects on tumor growth and progression. Additionally, it can demonstrate synergistic anticancer effects when combined with conventional chemotherapeutic drugs, enhancing chemo-sensitivity and efficacy in resistant cases.
4. Used in the Production of Related Compounds:
SPT1141 M6 is also used in the synthesis of related compounds, such as O-BOC-N-Pyruvyl Docetaxel, which is a derivative of the chemotherapy drug Docetaxel. SPT1141 M6 exhibits anti-mitotic properties and is used for treating various metastatic cancers.
Check Digit Verification of cas no
The CAS Registry Mumber 1021489-55-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,1,4,8 and 9 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1021489-55:
(9*1)+(8*0)+(7*2)+(6*1)+(5*4)+(4*8)+(3*9)+(2*5)+(1*5)=123
123 % 10 = 3
So 1021489-55-3 is a valid CAS Registry Number.
1021489-55-3Relevant academic research and scientific papers
Crystalline forms of docetaxel and process for preparation thereof
-
Page/Page column 3, (2008/12/04)
New anhydrous crystalline form of docetaxel and process of making anhydrous docetaxel and docetaxel trihydrate are provided.
